As hep C proves a ‘flash in the pan’ once again, Gilead’s sales will ‘erode massively’: Analyst

Posted: September 27th, 2016  |  Company/topic: Gilead
As hep C proves a 'flash in the pan' once again, Gilead's sales will 'erode massively': Analyst tracystaton Tue, 09/27/2016 - 12:16…

Sanofi, Regeneron’s eczema drug gains FDA priority review status

Posted: September 27th, 2016  |  Company/topic: Uncategorized
The FDA will give priority review to dupilumab, a new injectable atopic eczema drug by Sanofi and Regeneron Pharmaceuticals,  -More- …

Novartis oncology vet to head up cancer I/O startup Neon

Posted: September 27th, 2016  |  Company/topic: Novartis
Novartis oncology vet to head up cancer I/O startup Neon slawrence Tue, 09/27/2016 - 09:38…

Galapagos CEO confirms Gilead standstill agreement is active, quashing takeover talk

Posted: September 27th, 2016  |  Company/topic: Gilead
Galapagos CEO confirms Gilead standstill agreement is active, quashing takeover talk ntaylor Tue, 09/27/2016 - 09:35…